Alkermes plc (ALKS) Tops Q1 EPS by 9c, Reaffirms Guidnce
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Alkermes plc Reports First Quarter 2015 Financial Results
April 30, 2015 7:00 AM EDTFirst Quarter Revenues of $161.2 Million and Non-GAAP Diluted EPS of $0.06
Late-Stage Pipeline Advancing Rapidly as Company Progresses Pivotal Programs for ALKS 5461 in Depression, ALKS 3831 in Schizophrenia and ALKS 8700 in Multiple Sclerosis
Preparing for Launch of Aripiprazole Lauroxil for Schizophrenia
2015 Financial Expectations Reiterated
DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NASDAQ: ALKS) today... More
